Skip to main content
Molecular Therapy logoLink to Molecular Therapy
. 2023 Sep 25;31(11):3355–3356. doi: 10.1016/j.ymthe.2023.09.016

Di-valent siRNA-mediated silencing of MSH3 blocks somatic repeat expansion in mouse models of Huntington’s disease

Daniel O’Reilly, Jillian Belgrad, Chantal Ferguson, Ashley Summers, Ellen Sapp, Cassandra McHugh, Ella Mathews, Adel Boudi, Julianna Buchwald, Socheata Ly, Dimas Moreno, Raymond Furgal, Eric Luu, Zachary Kennedy, Vignesh Hariharan, Kathryn Monopoli, X William Yang, Jeffery Carroll, Marian DiFiglia, Neil Aronin, Anastasia Khvorova
PMCID: PMC10638064  PMID: 37751745

Main text

(Molecular Therapy 31, 1661–1674; June 2023)

In the originally published version of this article, the data for MSH2, PMS1, and PMS2 in Figure 6 were unintentionally duplicated. After reviewing the original data, the authors found that the MSH2 data had been accidentally copied and pasted into the PMS1 and PMS2 data cells during data analysis. The corrected figure has been provided below. The authors state that the conclusions of Figure 6 and the manuscript have not changed with this correction.

This article has been corrected online, and the authors apologize for any confusion this may have caused.

graphic file with name gr6c.jpg

Figure 6. MSH3 silencing does not alter expression of additional mismatch repair genes (corrected)

graphic file with name gr6o.jpg

Figure 6. MSH3 silencing does not alter expression of additional mismatch repair genes (original)


Articles from Molecular Therapy are provided here courtesy of The American Society of Gene & Cell Therapy

RESOURCES